Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381102 · ClinicalTrials.gov registry record · NA
Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT06381102: Completed NA study, sponsored by University of Miami.
NCT06381102 is a NA study that has completed, run by University of Miami. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06381102, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerability, as well as how well it works.
Primary Outcome
Tolerability will be assessed with a questionnaire with scores ranging from 0 -10 (with 0 being no irritation or discomfort and 10 being the worst possible irritation or discomfort) for irritation from tingling/tickling/pricking during taVNS.
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation 30/30
- DEVICE transcutaneous auricular vagus nerve stimulation 10/10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-04-13 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
What the finished NCT06381102 record still lists
NCT06381102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation 30/30 is the first listed.
NCT06381102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06381102 about?
NCT06381102 is a clinical study titled "Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1". The purpose of this research study is to investigate the effects of different forms of a gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS). The research team is interested in how the different forms affect comfort and tolerabi...
What is the current status of trial NCT06381102?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-04-13. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT06381102?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation 30/30 (DEVICE), transcutaneous auricular vagus nerve stimulation 10/10 (DEVICE).
Who is sponsoring clinical trial NCT06381102?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06381102's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI